Clinical Trials Browser

Phase 2 × Pleural Effusion, Malignant × cediranib × Clear all

NCT01262612 2013-07-15

Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion

Phase 2 Terminated

Pleural Effusion, Malignant